RxDoctor Payments Data

Cortney Seymour

Family · Columbus, OHNPI 1720333073

Payments from drug & device makers

$412in general payments, 2019–2025

Across 18 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$106
  • Otsuka America Pharmaceutical, Inc.$87
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$36
  • AstraZeneca$32
  • SK Life Science, Inc.$31
  • AbbVie$30
  • plus $91 from 5 others

What the payments were for

  • Food & beverage$412100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$412 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$73,008
Medicare patients
139
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate19$164,669
Invega SustennaPaliperidone Palmitate41$148,058
NuedextaDextromethorphan Hbr/Quinidine69$89,504
EliquisApixaban61$29,137
LinzessLinaclotide48$27,656
ValtocoDiazepam29$21,527
XareltoRivaroxaban43$18,673
MyrbetriqMirabegron49$16,683
LokelmaSodium Zirconium Cyclosilicate18$14,277
OzempicSemaglutide14$13,871
JardianceEmpagliflozin26$12,265
Lactulose127$9,713
Spiriva HandihalerTiotropium Bromide16$8,495
InvokanaCanagliflozin19$7,584
Atrovent HfaIpratropium Bromide15$7,424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$30$27,65648 claims
AstraZenecaLokelma$32$14,27718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →